Cell regulation by the Apc protein. Apc as master regulator of epithelia

Current Opinion in Cell Biology

Volumn 20, Issue 2, 2008, Pages 186-193

  McCartney, Brooke M ^a   Näthke, Inke S ^b  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BETA CATENIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLYCOGEN SYNTHASE KINASE 3; WNT PROTEIN;

APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; CELL MIGRATION; CELL PROLIFERATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; TRANSCRIPTION REGULATION;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; APOPTOSIS; CELL NUCLEUS; CELL PHYSIOLOGY; EPITHELIUM; HUMANS; WNT PROTEINS;

EID: 41549117418     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2008.02.001     Document Type: Review

References (62)

1. Su L.K., Kinzler K.W., Vogelstein B., Preisinger A.C., Moser A., Luongo C., Gould K.A., and Dove W.F. Multiple intestinal neoplasia caused by mutations in the murine homolog of the APC gene. Science 256 (1992) 668-670. This paper identifies the Apc locus as the site for mutations in intestinal neplasia.
2. Moser A.R., Dove W.F., Roth K.A., and Gordon J.I. The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J Cell Biol 116 (1992) 1517-1526. This paper identifies the Apc locus as the site for mutations in intesitnal neplasia, but also demonstrates the effects of genetic background on penetrance of phenotype
3. Moser A.R., Luongo C., Gould K.A., McNeley M.K., Shoemaker A.R., and Dove W.F. ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur J Cancer 31A (1995) 1061-1064. This paper established the causal relationship between Apc heterozygosity and intestinal neoplasia. The Min mouse described in this paper is one of the most commonly used mouse strains in the world.
4. Rubinfeld B., Souza B., Albert I., Müller O., Chamberlain S.H., Masiarz F.R., Munemitsu S., and Polakis P. Association of the APC gene product with β-catenin. Science 262 (1993) 1731-1734. This paper shows the interaction of Apc protein with β-catenin, which set the stage for the identifying the Wnt-regulated degradation of β-catenin as a central pathway in colon tumour development.
5. Su L.-K., Vogelstein B., and Kinzler K.W. Association of the APC tumor suppressor protein with catenins. Science 262 (1993) 1734-1737. Shows the interaction of Apc protein with β-catenin, which set the stage for the identifying the Wnt-regulated degradation of β-catenin as a central pathway in colon tumour development.
6. Polakis P. The many ways of Wnt in cancer. Curr Opin Genet Dev 17 (2007) 45-51
7. Kennell J, Cadigan K: APC and ß-catenin degradation. In APC proteins. Edited by Näthke IS, McCartney BM: Landes Bioscience; 2008, in press. http://www.eurekah.com/chapter/3776.
8. Rubinfeld B., Albert I., Porfiri E., Fiol C., Munemitsu S., and Polakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272 (1996) 1023-1026. This paper provides significant insights into the assembly and regulation of the complex that governs the degradation of β-catenin. Of particular importance to this discussion was the finding that the phosphorylation of the central repeat region of Apc significantly enhances its affinity for β-catenin.
9. Liu J., Xing Y., Hinds T.R., Zheng J., and Xu W. The third 20 amino acid repeat is the tightest binding site of APC for beta-catenin. J Mol Biol 360 (2006) 133-144. The authors present a detailed analysis of the binding affinities of individual phosphorylated and unphosphorylated 15R and 20R for β-catenin. They showed that individual repeats have distinct binding affinities, with 20R3 being the highest, and the phosphorylation increases the binding affinities for all of them. Furthermore, specific amino acids in the 20R N-terminal flanking sequences significantly enhance the binding affinities of unphosphorylated 20R for β-catenin. Further study is required to determine the functional significance of these distinctions.
10. ••].
11. ••] demonstrated that phosphorylated Apc (P-Apc) competes with Axin for binding to β-catenin, while non-P-Apc and Axin can bind β-catenin simultaneously. These findings suggest a novel model for interactions within the destruction complex. Phosphorylation may be a 'critical switch' for Apc outside of the destruction complex as well. Xing et al. 2004 showed that P-Apc competes with Tcf binding to β-catenin, and thus may provide an additional mechanism for the downregulation of β-catenin transcription by Apc.
12. Xing Y., Clements W.K., Kimelman D., and Xu W. Crystal structure of a beta-catenin/axin complex suggests a mechanism for the beta-catenin destruction complex. Genes Dev 17 (2003) 2753-2764. This paper provided important structural insights into the nature of the β-catenin-Axin complex that set the stage for the later structural work.
13. Gao Z.H., Seeling J.M., Hill V., Yochum A., and Virshup D.M. Casein kinase I phosphorylates and destabilizes the beta-catenin degradation complex. Proc Natl Acad Sci U S A 99 (2002) 1182-1187
14. Ikeda S., Kishida M., Matsuura Y., Usui H., and Kikuchi A. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin. Oncogene 19 (2000) 537-545
15. Hsu W., Zeng L., and Constantini F. Identification of a domain of Axin that binds to the serin/threonine protein phosphatase 2A and a self-binding domain. J Biol Chem 274 (1999) 3439-3445
16. Seeling J., Miller J., Gil R., Moon R., White R., and Virshup D. Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A. Science 283 (1999) 2089-2091. This paper demonstrates the involvement of PP2A as an important regulator of β-catenin degradation.
17. Yamamoto H., Hinoi T., Michiue T., Fukui A., Usui H., Janssens V., Van Hoof C., Goris J., Asashima M., and Kikuchi A. Inhibition of the Wnt signaling pathway by the PR61 subunit of protein phosphatase 2A. J Biol Chem 276 (2001) 26875-26882
18. McCartney B.M., Price M.H., Webb R.L., Hayden M.A., Holot L.M., Zhou M., Bejsovec A., and Peifer M. Testing hypotheses for the functions of APC family proteins using null and truncation alleles in Drosophila. Development 133 (2006) 2407-2418. The authors showed that Drosophila null for both Apc genes (Apc1 and APC2) do not exhibit significant defects in a variety of processes in which Apc has been implicated, including cell viability, cadherin-based adhesion, spindle morphology and orientation, or cytokinesis. Complete loss of Drosophila Apc proteins does result in significant activation of Wnt signalling throughout development. These findings are consistent with the hypothesis that although Apc proteins may function in many cellular processes, they are not strictly required for most of these processes, but rather function in their fidelity and/or efficiency.
19. Hart M., Concordet J.P., Lassot I., Albert I., del los Santos R., Durand H., Perret C., Rubinfeld B., Margottin F., Benarous R., et al. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol 9 (1999) 207-210
20. McCartney B.M., Dierick H.A., Kirkpatrick C., Moline M.M., Baas A., Peifer M., and Bejsovec A. Drosophila APC2 is a cytoskeletally-associated protein that regulates Wnt signaling in the embryonic epidermis. J Cell Biol 146 (1999) 1303-1318
21. Yu X., Waltzer L., and Bienz M. A new Drosophila APC homologue associated with adhesive zones of epithelial cells. Nat Cell Biol 1 (1999) 144-151
22. Louie R.K., Bahmanyar S., Siemers K.A., Votin V., Chang P., Stearns T., Nelson W.J., and Barth A.I. Adenomatous polyposis coli and EB1 localize in close proximity of the mother centriole and EB1 is a functional component of centrosomes. J Cell Sci 117 (2004) 1117-1128
23. Neufeld K: Nuclear APC. In APC proteins. Edited by Näthke IS, McCartney BM: Landes Bioscience; 2008, in press. http://www.eurekah.com/chapter/3835.
24. Zhang F., White R.L., and Neufeld K.L. Phosphorylation near nuclear localization signal regulates nuclear import of adenomatous polyposis coli protein. Proc Natl Acad Sci U S A 97 (2000) 12577-12582. This paper provided key evidence that the NLS activity of Apc is regulated by the phosphorylation of NLS flanking sites in two different ways. Phosphorylation by casein kinase 2 appears to enhance NLS activity, while phosphorylation by protein kinase A, inhibits NLS activity.
25. Hildesheim J., Salvador J.M., Hollander M.C., and Fornace Jr. A.J. Casein kinase 2- and protein kinase A-regulated adenomatous polyposis coli and beta-catenin cellular localization is dependent on p38 MAPK. J Biol Chem 280 (2005) 17221-17226
26. Homma M.K., Li D., Krebs E.G., Yuasa Y., and Homma Y. Association and regulation of casein kinase 2 activity by adenomatous polyposis coli protein. Proc Natl Acad Sci U S A 99 (2002) 5959-5964
27. Krieghoff E., Behrens J., and Mayr B. Nucleo-cytoplasmic distribution of beta-catenin is regulated by retention. J Cell Sci 119 (2006) 1453-1463. Using live cell imaging and fluorescence recovery after photobleaching, the authors demonstrated that none of the factors known to bind to β-catenin in the nucleus influence the rate of β-catenin nuclear import and export. Instead, these binding partners may act to sequester β-catenin in specific cellular compartments. This elegant study strongly supports the model that one function of Apc in the nucleus is to sequester β-catenin and thus downregulate its transcriptional activity.
28. Hamada F., and Bienz M. The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF. Dev Cell 7 (2004) 677-685
29. •].
30. •] provide evidence for additional roles for casein kinase 2 (CK2) in Wnt signalling. Not only does CK2 appear to regulate the nuclear localisation of Apc (24), but it also plays a role in the assembly of LEF1-β-catenin transcriptional complexes.
31. Mizumoto K., and Sawa H. Cortical beta-catenin and APC regulate asymmetric nuclear beta-catenin localization during asymmetric cell division in C. elegans. Dev Cell 12 (2007) 287-299
32. Deka J., Herter P., Sprenger-Haussels M., Koosch S., Franz D., Muller K.M., Kuhnen C., Hoffmann I., and Muller O. The APC protein binds to A/T rich DNA sequences. Oncogene 18 (1999) 5654-5661
33. Narayan S., Jaiswal A.S., and Balusu R. Tumor suppressor APC blocks DNA polymerase beta-dependent strand displacement synthesis during long patch but not short patch base excision repair and increases sensitivity to methylmethane sulfonate. J Biol Chem 280 (2005) 6942-6949
34. Bullen T.F., Forrest S., Campbell F., Dodson A.R., Hershman M.J., Pritchard D.M., Turner J.R., Montrose M.H., and Watson A.J. Characterization of epithelial cell shedding from human small intestine. Lab Invest 86 (2006) 1052-1063
35. Benchabane H, Ahmed Y: The adenomatous polyposis coli tumor suppressor and wnt signaling in the regulation of apoptosis. In APC Proteins. Edited by Näthke IS, McCartney BM. Landes Bioscience, vol 1; 2008, in press. http://www.eurekah.com/chapter/3784.
36. Ioannidis V., Beermann F., Clevers H., and Held W. The beta-catenin - TCF-1 pathway ensures CD4(+)CD8(+) thymocyte survival. Nat Immunol 2 (2001) 691-697
37. Huang M., Wang Y., Sun D., Zhu H., Yin Y., Zhang W., Yang S., Quan L., Bai J., Wang S., et al. Identification of genes regulated by Wnt/beta-catenin pathway and involved in apoptosis via microarray analysis. BMC Cancer 6 (2006) 221
38. Dikovskaya D., Schiffmann D., Newton I.P., Oakley A., Kroboth K., Sansom O., Jamieson T.J., Meniel V., Clarke A., and Näthke I.S. Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis. J Cell Biol 176 (2007) 183-195. This paper demonstrates immediate defects in cell cycle machinery, including the spindle checkpoint, after the loss of Apc in cells and tissue.
39. Kroboth K., Newton I.P., Kita K., Dikovskaya D., Zumbrunn J., Waterman-Storer C.M., and Näthke I.S. Lack of adenomatous polyposis coli protein correlates with a decrease in cell migration and overall changes in microtubule stability. Mol Biol Cell 18 (2007) 910-918. This paper shows that Apc status correlates with over microtubule stability in cells and affects cell migration.
40. Etienne-Manneville S., and Hall A. Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity. Nature 421 (2003) 753-756. This paper provides important link between small GTPases and Apc in migrating protrusions.
41. Etienne-Manneville S., Manneville J.B., Nicholls S., Ferenczi M.A., and Hall A. Cdc42 and Par6-PKCzeta regulate the spatially localized association of Dlg1 and APC to control cell polarization. J Cell Biol 170 (2005) 895-901
42. Munemitsu S., Souza B., Müller O., Albert I., Rubinfeld B., and Polakis P. The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 54 (1994) 3676-3681. This is the first demonstration that Apc can bind to microtubules.
43. Zumbrunn J., Inoshita K., Hyman A.A., and Näthke I.S. Binding of the adenomatous polyposis coli protein to microtubules increases microtubule stability and is regulated by GSK3b phosphorylation. Curr Biol 11 (2001) 44-49. This paper shows the direct effect of Apc on microtubule stability in vitro and in cells and provides evidence that this function can be regulated by the phosphorylation with GSK3b.
44. Kita K., Wittmann T., Näthke I.S., and Waterman-Storer C.M. APC on microtubule plus ends in cell extensions can promote microtubule net growth with or without EB1. Mol Biol Cell 17 (2006) 2331-2345. This paper demonstrates direct link between endogenous Apc protein and microtubule dynamics in cells.
45. Su L.-K., Burrell M., Hill D.E., Gyuris J., Brent R., Wiltshire R., Trent J., Vogelstein B., and Kinzler K.W. APC binds to the novel protein EB1. Cancer Res 55 (1995) 2972-2977. This paper identifies EB1 as an Apc binding partner and thus brings Apc closer to the microtubule cytoskeleton.
46. Moseley J.B., Bartolini F., Okada K., Wen Y., Gundersen G.G., and Goode B.L. Regulated binding of adenomatous polyposis coli protein to actin. J Biol Chem 282 (2007) 12661-12668
47. Kawasaki Y., Senda T., Ishidate T., Koyama R., Morishita T., Iwayama Y., Higuchi O., and Akiyama T. Asef, a link between the tumor suppressor APC and G-protein signaling. Science 289 (2000) 1194-1197. Identifies Apc as a regulator for the activity of an exchange factor for small GTP-ases thus establishing a functional link between Apc and actin.
48. Watanabe T., Wang S., Noritake J., Sato K., Fukata M., Takefuji M., Nakagawa M., Izumi N., Akiyama T., and Kaibuchi K. Interaction with IQGAP1 links APC to Rac1, Cdc42, and actin filaments during cell polarization and migration. Dev Cell 7 (2004) 871-883
49. Wen Y., Eng C.H., Schmoranzer J., Cabrera-Poch N., Morris E.J., Chen M., Wallar B.J., Alberts A.S., and Gundersen G.G. EB1 and APC bind to mDia to stabilize microtubules downstream of Rho and promote cell migration. Nat Cell Biol 6 (2004) 820-830
50. Sansom O.J., Reed K.R., Hayes A.J., Ireland H., Brinkmann H., Newton I.P., Batlle E., Simon-Assmann P., Clevers H., Näthke I.S., et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev 18 (2004) 1385-1390. Shows that conditionally inactivating Apc in the gut immediately leads to changes that underlie tumourigenesis.
51. Draviam V.M., Shapiro I., Aldridge B., and Sorger P.K. Misorientation and reduced stretching of aligned sister kinetochores promote chromosome missegregation in EB1- or APC-depleted cells. EMBO J 25 (2006) 2814-2827
52. Aoki K., Aoki M., Sugai M., Harada N., Miyoshi H., Tsukamoto T., Mizoshita T., Tatematsu M., Seno H., Chiba T., et al. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells. Oncogene 26 (2007) 3511-3520
53. Green R.A., and Kaplan K.B. Chromosome instability in colorectal tumor cells is associated with defects in microtubule plus-end attachments caused by a dominant mutation in APC. J Cell Biol 163 (2003) 949-961. This paper demonstrates a dominant effect of N-terminal Apc fragments in mitosis.
54. Caldwell C.M., Green R.A., and Kaplan K.B. APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in Min mice. J Cell Biol 178 (2007) 1109-1120
55. 2-terminal fragments are the most stable part of the adenomatous polyposis coli protein and can be regulated by interactions with COOH-terminal domains. Cancer Res 65 (2005) 5195-5204
56. Green R.A., Wollman R., and Kaplan K.B. APC and EB1 function together in mitosis to regulate spindle dynamics and chromosome alignment. Mol Biol Cell 16 (2005) 4609-4622
57. Berrueta L., Tirnauer J.S., Schuyler S.C., Pellman D., and Bierer B.E. The APC-associated protein EB1 associates with components of the dynactin complex and cytoplasmic dynein intermediate chain. Curr Biol 9 (1999) 425-428
58. Strickland L.I., Wen Y., Gundersen G.G., and Burgess D.R. Interaction between EB1 and p150glued is required for anaphase astral microtubule elongation and stimulation of cytokinesis. Curr Biol 15 (2005) 2249-2255
59. McCartney B.M., McEwen D.G., Grevengoed E., Maddox P., Bejsovec A., and Peifer M. Drosophila APC2 and Armadillo participate in tethering mitotic spindles to cortical actin. Nat Cell Biol 3 (2001) 933-938
60. Amos-Landgraf J.M., Kwong L.N., Kendziorski C.M., Reichelderfer M., Torrealba J., Weichert J., Haag J.D., Chen K.S., Waller J.L., Gould M.N., et al. A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer. Proc Natl Acad Sci U S A 104 (2007) 4036-4041. This paper introduces a novel rat model for Apc-mediated tumourigenesis that mimics the human disease more accurately.
61. Sansom O.J., Meniel V.S., Muncan V., Phesse T.J., Wilkins J.A., Reed K.R., Vass J.K., Athineos D., Clevers H., and Clarke A.R. Myc deletion rescues Apc deficiency in the small intestine. Nature 446 (2007) 676-679. This paper demonstrates that Myc is absolutely required for Apc-deficient cells to survive in intestinal tissue and form tumours and that de-regulated, nuclear β-catenin is not sufficient.
62. Hart M.J., de los Santos R., Albert I., Rubinfeld B., and Polakis P. Downregulation of ß-catenin by human axin and its association with the APC tumor suppressor, ß-catenin and GSK3ß. Curr Biol 8 (1998) 573-581